Talk:MDPHP: Difference between revisions

Line 1:

'''3',4'-Methylenedioxy-α-pyrrolidinohexiophenone''' (also known as '''MDPHP''' and '''Monkey Dust''') is a synthetic [[~~entactogens|entactogenic~~]] [[~~stimulant~~]] ~~of the~~ [[~~Substituted cathinone~~]] ~~class~~, and its commonly reported effects include [[stimulation]], [[disinhibition]], [[increased libido]], [[compulsive redosing]], and [[euphoria]] when [[Routes_of_administration|administered]] orally, insufflated or smoked.

'''3',4'-Methylenedioxy-α-pyrrolidinohexiophenone''' (also known as '''MDPHP''' and '''Monkey Dust''') is a synthetic [[stimulant]] of the [[substituted cathinone|cathinone]] and [[substituted pyrrolidine|pyrrolidine]] classes, and its commonly reported effects include [[stimulation]], [[disinhibition]], [[increased libido]], [[compulsive redosing]], and [[euphoria]] when [[Routes_of_administration|administered]] orally, insufflated or smoked. MDPHP is thought to act primarily as a [[norepinephrine]]-[[dopamine]] [[reuptake inhibitor]] (NDRI).

MDPHP was first developed in the 1960s by a team at Boehringer Ingelheim<ref name="KoppePatent">{{cite patent | country = DE | number = 1545591 | inventor = Koeppe H, Zeile K, Ludwig G |title=Patent DE - Verfahren zur Herstellung von α-Aminoketonen mit heterocyclischer Aminogruppe |url=https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19690807&DB=&locale=en_EP&CC=DE&NR=1545591A1&KC=A1|gdate =28 May 1965}}</ref>

Like other [[Substituted cathinone|Substituted cathinones]], MDPHP is associated with compulsive use and addiction. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPHP. Due to its potent psychostimulant effects and unknown toxicity profile, it is highly advised to use [[harm reduction practices]] if choosing to use this substance.

@@ Line 1: / Line 1: @@
 {{SubstanceBox}}
-'''3',4'-Methylenedioxy-α-pyrrolidinohexiophenone''' (also known as '''MDPHP''' and '''Monkey Dust''') is a synthetic [[entactogens|entactogenic]] [[stimulant]] of the [[Substituted cathinone]] class, and its commonly reported effects include [[stimulation]], [[disinhibition]], [[increased libido]], [[compulsive redosing]], and [[euphoria]] when [[Routes_of_administration|administered]] orally, insufflated or smoked.
+'''3',4'-Methylenedioxy-α-pyrrolidinohexiophenone''' (also known as '''MDPHP''' and '''Monkey Dust''') is a synthetic [[stimulant]] of the [[substituted cathinone|cathinone]] and [[substituted pyrrolidine|pyrrolidine]] classes, and its commonly reported effects include [[stimulation]], [[disinhibition]], [[increased libido]], [[compulsive redosing]], and [[euphoria]] when [[Routes_of_administration|administered]] orally, insufflated or smoked. MDPHP is thought to act primarily as a [[norepinephrine]]-[[dopamine]] [[reuptake inhibitor]] (NDRI).
+MDPHP was first developed in the 1960s by a team at Boehringer Ingelheim<ref name="KoppePatent">{{cite patent | country = DE | number = 1545591 | inventor = Koeppe H, Zeile K, Ludwig G |title=Patent DE - Verfahren zur Herstellung von α-Aminoketonen mit heterocyclischer Aminogruppe |url=https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19690807&DB=&locale=en_EP&CC=DE&NR=1545591A1&KC=A1|gdate =28 May 1965}}</ref>
 Like other [[Substituted cathinone|Substituted cathinones]], MDPHP is associated with compulsive use and addiction. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPHP. Due to its potent psychostimulant effects and unknown toxicity profile, it is highly advised to use [[harm reduction practices]] if choosing to use this substance.